论文部分内容阅读
目的观察通脉止血方治疗小儿免疫性血小板减少性紫癜(ITP)的临床疗效。方法 60例急性ITP患儿,随机分为对照组和治疗组,各30例。对照组给予泼尼松治疗,治疗组给予泼尼松联合通脉止血方治疗。对比两组疗效。结果治疗组总有效率为93.33%,高于对照的66.67%(P<0.05)。治疗组治疗1、4、12周后血小板(PLT)水平高于对照组,差异具有统计学意义(P<0.05)。治疗组未发现明显不良反应。对照组出现头痛4例,倦怠乏力6例。治疗组不良反应发生率为0,低于对照组的33.33%(P<0.05)。结论通脉止血方治疗小儿ITP效果确切,可有效减少PLT破坏,不良反应少,安全可靠,值得临床推广。
Objective To observe the clinical effect of Tongmai heixue decoction in treating infantile immune thrombocytopenic purpura (ITP). Methods Sixty children with acute ITP were randomly divided into control group and treatment group, with 30 cases in each group. The control group was given prednisone, and the treatment group was treated with prednisone combined with Tongmai hemostasis. Compare two groups curative effect. Results The total effective rate was 93.33% in the treatment group, which was 66.67% higher than that in the control group (P <0.05). The level of platelet (PLT) in the treatment group after 1, 4, and 12 weeks of treatment was significantly higher than that in the control group (P <0.05). The treatment group found no significant adverse reactions. The control group had 4 cases of headache, fatigue and fatigue in 6 cases. The incidence of adverse reactions in the treatment group was 0, which was lower than 33.33% of the control group (P <0.05). Conclusion Tongmai hemostatic treatment of children with ITP exact effect, which can effectively reduce the destruction of PLT, fewer adverse reactions, safe and reliable, worthy of clinical promotion.